FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lombardi, A. M.
Right arrow Articles by Leturque, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lombardi, A. M.
Right arrow Articles by Leturque, A.

The FASEB Journal, Vol 11, 1137-1144, Copyright © 1997 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Phenotype of transgenic mice overexpressing GLUT4 and hexokinase II in muscle

AM Lombardi, D Moller, M Loizeau, J Girard and A Leturque
Institute of Semeiotica Medica, University of Padova, Italy.

To optimize glucose utilization, double transgenic mice were created by crossing mice overexpressing glucose transporter GLUT4 with mice overexpressing hexokinase (HKII) in muscle. Transgenic mice overexpressing GLUT4 alone have exhibited improvements in glucose tolerance and insulin action. In vitro studies of hexose uptake in soleus muscle from transgenic mice suggested that GLUT4 was limiting the glucose flux except at high glucose concentration, where hexokinase became the limiting step. In vivo, glucose tolerance was similar in GLUT4 and GLUT4/HKII mice, although stimulated plasma insulin values were significantly lower in the latter group. Insulin tolerance tests performed in diabetic GLUT4 vs. diabetic GLUT4/HKII transgenic mice yielded identical results. Again, endogenous insulin in GLUT4/HKII mice during a mild hyperglycemic clamp was stimulated by only two- vs. fourfold in GLUT4 mice. Although the overexpression of HKII alone resulted in increased glucose utilization in several muscles, the overexpression of GLUT4 plus HKII did not augment basal or stimulated in vivo glucose utilization compared to GLUT4 overexpression. In conclusion, GLUT4 is rate limiting for muscle glucose utilization but HKII might be important under hyperglycemia. The addition of HKII to GLUT4 overexpression is not sufficient to further augment glucose tolerance or insulin action. In GLUT4/HKII double transgenic mice, glucose clearance is tempered by a low insulin stimulated level.


This article has been cited by other articles:


Home page
 DiabetesHome page
A. Mas, J. Montane, X. M. Anguela, S. Munoz, A. M. Douar, E. Riu, P. Otaegui, and F. Bosch
Reversal of Type 1 Diabetes by Engineering a Glucose Sensor in Skeletal Muscle
Diabetes, June 1, 2006; 55(6): 1546 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
P. T Fueger, J. Shearer, D. P Bracy, K. A Posey, R. R. Pencek, O. P McGuinness, and D. H Wasserman
Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice
J. Physiol., February 1, 2005; 562(3): 925 - 935.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. T. Fueger, H. S. Hess, K. A. Posey, D. P. Bracy, R. R. Pencek, M. J. Charron, and D. H. Wasserman
Control of Exercise-stimulated Muscle Glucose Uptake by GLUT4 Is Dependent on Glucose Phosphorylation Capacity in the Conscious Mouse
J. Biol. Chem., December 3, 2004; 279(49): 50956 - 50961.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. T. Fueger, D. P. Bracy, C. M. Malabanan, R. R. Pencek, and D. H. Wasserman
Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E77 - E84.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Ahmad, S. Ahmad, B. K. Schneider, C. B. Allen, L.-Y. Chang, and C. W. White
Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L573 - L584.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Q. Liang, R. V Donthi, P. M Kralik, and P. N Epstein
Elevated hexokinase increases cardiac glycolysis in transgenic mice
Cardiovasc Res, February 1, 2002; 53(2): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. H. McNulty
Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease
Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H741 - H747.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Heikkinen, M. Pietila, M. Halmekyto, S. Suppola, E. Pirinen, S. S. Deeb, J. Janne, and M. Laakso
Hexokinase II-deficient Mice. PRENATAL DEATH OF HOMOZYGOTES WITHOUT DISTURBANCES IN GLUCOSE TOLERANCE IN HETEROZYGOTES
J. Biol. Chem., August 6, 1999; 274(32): 22517 - 22523.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Hansen, B. A. Marshall, M. Chen, J. O. Holloszy, and M. Mueckler
Transgenic Overexpression of Hexokinase II in Skeletal Muscle Does Not Increase Glucose Disposal in Wild-type or Glut1-overexpressing Mice
J. Biol. Chem., July 14, 2000; 275(29): 22381 - 22386.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The Federation of American Societies for Experimental Biology.